Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 10, Pages 1855
Publisher
MDPI AG
Online
2019-05-14
DOI
10.3390/molecules24101855
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies
- (2019) Starlynn C. Clarke et al. Frontiers in Immunology
- Modulating Antibody–Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification
- (2018) Dian Su et al. BIOCONJUGATE CHEMISTRY
- Peptides for optical medical imaging and steps towards therapy
- (2018) Matteo Staderini et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Are all gonadotrophin-releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review
- (2018) Eva M. Bolton et al. BJU INTERNATIONAL
- Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
- (2018) Dereje Kebebe et al. International Journal of Nanomedicine
- Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice
- (2018) Yasuaki Anami et al. Nature Communications
- Bispecific antibodies: design, therapy, perspectives
- (2018) Sergey Sedykh et al. Drug Design Development and Therapy
- Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library
- (2018) Anna Demartis et al. Scientific Reports
- First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours
- (2017) Patrick Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
- (2017) Shama Dissanayake et al. JOURNAL OF CONTROLLED RELEASE
- The Current State of Peptide Drug Discovery: Back to the Future?
- (2017) Antoine Henninot et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes
- (2017) Sara T. Hjuler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Gemcitabine Based Peptide Conjugate with Improved Metabolic Properties and Dual Mode of Efficacy
- (2017) Theodoros Karampelas et al. MOLECULAR PHARMACEUTICS
- A fully automated flow-based approach for accelerated peptide synthesis
- (2017) Alexander J Mijalis et al. Nature Chemical Biology
- Bispecific antibody pipeline moves beyond oncology
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthesis of tri-functionalized MMP2 FRET probes using a chemo-selective and late-stage modification of unprotected peptides
- (2017) Sean Oriana et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- The New Biology and Pharmacology of Glucagon
- (2017) T. D. Müller et al. PHYSIOLOGICAL REVIEWS
- Lysine Analogue of Polymyxin B as a Significant Opportunity for Photodynamic Antimicrobial Chemotherapy
- (2017) Florent Le Guern et al. ACS Medicinal Chemistry Letters
- Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
- (2017) Sigrid Jall et al. Molecular Metabolism
- Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant
- (2017) Oscar B. Torres et al. npj Vaccines
- BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas
- (2017) Alejandro Ibáñez-Costa et al. Scientific Reports
- Structural and Functional View of Polypharmacology
- (2017) Aurelio Moya-García et al. Scientific Reports
- Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins
- (2017) M. Speir et al. Scientific Reports
- Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation
- (2016) Nick Cox et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody–Maytansinoid Conjugates
- (2016) Jose F. Ponte et al. BIOCONJUGATE CHEMISTRY
- Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours
- (2016) D Mahalingam et al. BRITISH JOURNAL OF CANCER
- Antibody-drug conjugates—an emerging class of cancer treatment
- (2016) Nikolaos Diamantis et al. BRITISH JOURNAL OF CANCER
- Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease
- (2016) Brian Finan et al. CELL
- Chemical Protein Modification through Cysteine
- (2016) Smita B. Gunnoo et al. CHEMBIOCHEM
- Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up
- (2016) Dieter Hörsch et al. EUROPEAN JOURNAL OF CANCER
- Linkers Having a Crucial Role in Antibody–Drug Conjugates
- (2016) Jun Lu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study
- (2016) Romain Coriat et al. International Journal of Nanomedicine
- Current Status: Site-Specific Antibody Drug Conjugates
- (2016) Dominik Schumacher et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Advances in Fmoc solid-phase peptide synthesis
- (2016) Raymond Behrendt et al. JOURNAL OF PEPTIDE SCIENCE
- Polypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges
- (2016) Oleksandr Zagorodko et al. MACROMOLECULAR BIOSCIENCE
- Peptide receptor radionuclide therapy for metastatic paragangliomas
- (2016) David J. Pinato et al. MEDICAL ONCOLOGY
- Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody–drug conjugates
- (2016) Leanna R. Staben et al. Nature Chemistry
- C–H activation: Complex peptides made simple
- (2016) Sean Bartlett et al. Nature Chemistry
- Recent advances in the construction of antibody–drug conjugates
- (2016) Vijay Chudasama et al. Nature Chemistry
- Integrin-based therapeutics: biological basis, clinical use and new drugs
- (2016) Klaus Ley et al. NATURE REVIEWS DRUG DISCOVERY
- Trends in clinical success rates
- (2016) Katarzyna Smietana et al. NATURE REVIEWS DRUG DISCOVERY
- A comprehensive map of molecular drug targets
- (2016) Rita Santos et al. NATURE REVIEWS DRUG DISCOVERY
- GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight
- (2016) Heike Vogel et al. NEUROPHARMACOLOGY
- On-resin Diels–Alder reaction with inverse electron demand: an efficient ligation method for complex peptides with a varying spacer to optimize cell adhesion
- (2016) Mareen Pagel et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Bioconjugation – using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers
- (2016) Smita B. Gunnoo et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer
- (2016) Selin Seda Timur et al. PHARMACEUTICAL RESEARCH
- Antibody-drug conjugates: Current status and future perspectives
- (2016) Rémy Gébleux et al. PHARMACOLOGY & THERAPEUTICS
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer
- (2016) Cameron P. Capper et al. Hormones & Cancer
- MAKING PEPTIDES AT LARGE SCALE
- (2016) ANN M. THAYER CHEMICAL & ENGINEERING NEWS
- 2-(Maleimidomethyl)-1,3-Dioxanes (MD): a Serum-Stable Self-hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation
- (2016) Igor Dovgan et al. Scientific Reports
- Raloxifene for older women: a review of the literature
- (2016) H Hansdottir Clinical Interventions in Aging
- Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
- (2015) Jessica R. McCombs et al. AAPS Journal
- Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry
- (2015) Michael P. VanBrunt et al. BIOCONJUGATE CHEMISTRY
- Efficacy, but Not Antibody Titer or Affinity, of a Heroin Hapten Conjugate Vaccine Correlates with Increasing Hapten Densities on Tetanus Toxoid, but Not on CRM197 Carriers
- (2015) Rashmi Jalah et al. BIOCONJUGATE CHEMISTRY
- Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
- (2015) Eunhee G. Kim et al. Biomolecules & Therapeutics
- Current methods for the synthesis of homogeneous antibody–drug conjugates
- (2015) Alicja M. Sochaj et al. BIOTECHNOLOGY ADVANCES
- Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation
- (2015) Oleksandr Koniev et al. CHEMICAL SOCIETY REVIEWS
- Controlling Toxicity of Peptide-Drug Conjugates by Different Chemical Linker Structures
- (2015) David Böhme et al. ChemMedChem
- Protein–polymer conjugation—moving beyond PEGylation
- (2015) Yizhi Qi et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development
- (2015) Nhu Quynh Doan et al. CURRENT PHARMACEUTICAL DESIGN
- A smart tumor targeting peptide–drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells
- (2015) Qin Song et al. DRUG DELIVERY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Timing of Estradiol Treatment After Menopause May Determine Benefit or Harm to Insulin Action
- (2015) R. I. Pereira et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
- Subconjunctival Injection of XG-102, a JNK Inhibitor Peptide, in Patients with Intraocular Inflammation: A Safety and Tolerability Study
- (2015) Talal Beydoun et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs
- (2015) Christopher R. Behrens et al. MOLECULAR PHARMACEUTICS
- Enhanced Peptide Stability Against Protease Digestion Induced by Intrinsic Factor Binding of a Vitamin B12 Conjugate of Exendin-4
- (2015) Ron L. Bonaccorso et al. MOLECULAR PHARMACEUTICS
- Thapsigargin—From Thapsia L. to Mipsagargin
- (2015) Trine Andersen et al. MOLECULES
- An analysis of the attrition of drug candidates from four major pharmaceutical companies
- (2015) Michael J. Waring et al. NATURE REVIEWS DRUG DISCOVERY
- Solid-Phase S-Alkylation Promoted by Molecular Sieves
- (2015) Enrica Calce et al. ORGANIC LETTERS
- Current ADC Linker Chemistry
- (2015) Nareshkumar Jain et al. PHARMACEUTICAL RESEARCH
- A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
- (2015) Antoine Maruani et al. Nature Communications
- Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis
- (2015) Joseph P. Tiano et al. Scientific Reports
- Estrogen: An Emerging Regulator of Insulin Action and Mitochondrial Function
- (2015) Anisha A. Gupte et al. Journal of Diabetes Research
- Engineering Enzymatically Activated “Molecular Grenades” for Cancer
- (2015) Samuel R. Denmeade et al. Oncotarget
- Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract
- (2014) Jose Barrera et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats
- (2014) Kim V. Andreassen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Automated solid-phase peptide synthesis to obtain therapeutic peptides
- (2014) Veronika Mäde et al. Beilstein Journal of Organic Chemistry
- Affinity-Guided Covalent Conjugation Reactions Based on PDZ–Peptide and SH3–Peptide Interactions
- (2014) Yao Lu et al. BIOCONJUGATE CHEMISTRY
- Long-Term Stabilization of Maleimide–Thiol Conjugates
- (2014) Shaun D. Fontaine et al. BIOCONJUGATE CHEMISTRY
- Antibody–drug conjugates—A new wave of cancer drugs
- (2014) Hervé Bouchard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors
- (2014) Kelly K. Curtis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Design, Synthesis and Bioevaluation of an EphA2 Receptor-Based Targeted Delivery System
- (2014) Elisa Barile et al. ChemMedChem
- Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer
- (2014) S. V. Liu et al. CLINICAL CANCER RESEARCH
- Biopharmaceutical discovery and production in yeast
- (2014) Michael A Meehl et al. CURRENT OPINION IN BIOTECHNOLOGY
- GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
- (2014) Robert W. Schwenk et al. DIABETOLOGIA
- Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5)
- (2014) Günter Emons et al. GYNECOLOGIC ONCOLOGY
- Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors
- (2014) Günter Emons et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice
- (2014) Xuehong Cao et al. JOURNAL OF CLINICAL INVESTIGATION
- Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer
- (2014) John M. Lambert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cell factories for insulin production
- (2014) Nabih A Baeshen et al. Microbial Cell Factories
- Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates
- (2014) Robert P Lyon et al. NATURE BIOTECHNOLOGY
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- Solid phase oxime ligations for the iterative synthesis of polypeptide conjugates
- (2014) Isidore E. Decostaire et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
- (2014) Felix F. Schumacher et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Thyroid Hormone Regulation of Metabolism
- (2014) Rashmi Mullur et al. PHYSIOLOGICAL REVIEWS
- Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism
- (2014) Rohit A. Sinha et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Selective chemical protein modification
- (2014) Christopher D. Spicer et al. Nature Communications
- Recent advances in S–S bond formation
- (2014) Bablee Mandal et al. RSC Advances
- Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice
- (2014) Jun Ho Kim et al. Molecular Metabolism
- Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
- (2013) Nicolas Ochs et al. ANNALS OF INTERNAL MEDICINE
- Phase I Study of GRN1005 in Recurrent Malignant Glioma
- (2013) J. Drappatz et al. CLINICAL CANCER RESEARCH
- Future directions for peptide therapeutics development
- (2013) Allan A. Kaspar et al. DRUG DISCOVERY TODAY
- Antibody–drug conjugates: current status and future directions
- (2013) Heidi L. Perez et al. DRUG DISCOVERY TODAY
- Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
- (2013) L. Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1, and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice
- (2013) Victor A. Gault et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases
- (2013) Mazen Jamous et al. MOLECULES
- Novelty in the target landscape of the pharmaceutical industry
- (2013) Pankaj Agarwal et al. NATURE REVIEWS DRUG DISCOVERY
- Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
- (2013) Sharon A. Sadry et al. Nature Reviews Endocrinology
- Chemical Modifications of Peptide Sequences via S-Alkylation Reaction
- (2013) Enrica Calce et al. ORGANIC LETTERS
- The Safety and Efficacy of KAI-1678— An Inhibitor of Epsilon Protein Kinase C (εPKC)—Versus Lidocaine and Placebo for the Treatment of Postherpetic Neuralgia: A Crossover Study Design
- (2013) Michael J. Cousins et al. PAIN MEDICINE
- A Single-Center, Randomized, Double-Blind, Active, and Placebo-Controlled Study of KAI-1678, a Novel PKC-Epsilon Inhibitor, in the Treatment of Acute Postoperative Orthopedic Pain
- (2013) John E. Moodie et al. PAIN MEDICINE
- A review of the use of somatostatin analogs in oncology
- (2013) Suayib Yalcin et al. OncoTargets and Therapy
- Molecular Mechanisms of Gonadotropin-Releasing Hormone Signaling: Integrating Cyclic Nucleotides into the Network
- (2013) Rebecca M. Perrett et al. Frontiers in Endocrinology
- Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer
- (2012) Donald W. Northfelt et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Peptide–Drug Conjugate Linked via a Disulfide Bond for Kidney Targeted Drug Delivery
- (2012) Qian Geng et al. BIOCONJUGATE CHEMISTRY
- AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors
- (2012) Joerg Engel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeted drug delivery for cancer therapy: the other side of antibodies
- (2012) Michael A Firer et al. Journal of Hematology & Oncology
- Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells
- (2012) Si Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Targeted estrogen delivery reverses the metabolic syndrome
- (2012) Brian Finan et al. NATURE MEDICINE
- Brentuximab vedotin
- (2012) Anas Younes et al. NATURE REVIEWS DRUG DISCOVERY
- Engineering a Prostate-Specific Membrane Antigen-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy
- (2012) S. R. Denmeade et al. Science Translational Medicine
- Pharmacokinetic drivers of toxicity for basic molecules: Strategy to lower pKa results in decreased tissue exposure and toxicity for a small molecule Met inhibitor
- (2012) Dolores Diaz et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Polypharmacology: drug discovery for the future
- (2012) A Srinivas Reddy et al. Expert Review of Clinical Pharmacology
- Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1
- (2011) Y Bertrand et al. BRITISH JOURNAL OF CANCER
- Peptide Coupling Reagents, More than a Letter Soup
- (2011) Ayman El-Faham et al. CHEMICAL REVIEWS
- Distribution of KAI-9803, a Novel -Protein Kinase C Inhibitor, after Intravenous Administration to Rats
- (2011) Y. Miyaji et al. DRUG METABOLISM AND DISPOSITION
- Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors
- (2011) R. Kurzrock et al. MOLECULAR CANCER THERAPEUTICS
- Contemporary strategies for peptide macrocyclization
- (2011) Christopher J. White et al. Nature Chemistry
- Solid-phase synthesis of biaryl cyclic peptides by borylation and microwave-assisted intramolecular Suzuki–Miyaura reaction
- (2011) Ana Afonso et al. TETRAHEDRON
- Important role of integrins in the cancer biology
- (2010) R. Rathinam et al. CANCER AND METASTASIS REVIEWS
- Steroid hormones drive cancer development
- (2010) SubbaRao V. Madhunapantula et al. CANCER BIOLOGY & THERAPY
- Protein Chemical Modification on Endogenous Amino Acids
- (2010) Emmanuel Baslé et al. CHEMISTRY & BIOLOGY
- Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors
- (2010) Günter Emons et al. GYNECOLOGIC ONCOLOGY
- Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain
- (2010) Kun Shao et al. JOURNAL OF CONTROLLED RELEASE
- Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2010) Mary E.R. O'Brien et al. Journal of Thoracic Oncology
- Integrins as therapeutic targets: lessons and opportunities
- (2010) Dermot Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity
- (2010) Franck Mauvais-Jarvis TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Design, Synthesis, and Biological Evaluation of Antibody−Drug Conjugates Comprised of Potent Camptothecin Analogues
- (2009) Patrick J. Burke et al. BIOCONJUGATE CHEMISTRY
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2009) Corey J. Langer et al. Journal of Thoracic Oncology
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
- (2009) John D. Baxter et al. NATURE REVIEWS DRUG DISCOVERY
- Novel Peptide Linkers for Highly Potent Antibody−Auristatin Conjugate
- (2008) Svetlana O. Doronina et al. BIOCONJUGATE CHEMISTRY
- Bruce Merrifield and solid-phase peptide synthesis: A historical assessment
- (2008) Alexander R. Mitchell BIOPOLYMERS
- Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
- (2008) L Paz-Ares et al. BRITISH JOURNAL OF CANCER
- Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
- (2008) A Régina et al. BRITISH JOURNAL OF PHARMACOLOGY
- Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
- (2008) CIRCULATION
- Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin
- (2008) D. Ravel et al. CLINICAL CANCER RESEARCH
- DTS-108, A Novel Peptidic Prodrug of SN38: In vivo Efficacy and Toxicokinetic Studies
- (2008) F. Meyer-Losic et al. CLINICAL CANCER RESEARCH
- Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study
- (2008) T. Florio et al. ENDOCRINE-RELATED CANCER
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent Developments in Disulfide Bond Formation
- (2008) Dariusz Witt SYNTHESIS-STUTTGART
- Effectiveness of the Suzuki−Miyaura Cross-Coupling Reaction for Solid-Phase Peptide Modification
- (2007) Ngoc-Duc Doan et al. JOURNAL OF COMBINATORIAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started